Chronic Kidney Disease

Oral ferric citrate may affectively raise hemoglobin levels in patients with anemia.

Proton pump inhibitors and histamine receptor-2 blockers have damaging effects on the kidneys.

Pharmacokinetics of anticoagulant tecarfarin not compromised by renal function as seen with warfarin.

Pharmacokinetics of tecarfarin were not compromised by renal function like it was with warfarin.

Although it was previously found that kidney disease can cause diabetes, the diseases also have an inverse relationship.

Increased genetic knowledge about non-whites could lead to improved knowledge and treatments.

It's important to take renal function into consideration when dosing renally-eliminated medications.

Patients with chronic kidney disease who had negative thoughts and feelings had worse outcomes.

Alternative sources of protein such as soy and legumes could protect against kidney failure.

A build-up of a metabolite found in urine could contribute to health problems faced by patients with kidney disease.

A build-up of a metabolite found in urine could contribute to health problems faced by patients with kidney disease.

Calcifediol (Rayaldee) extended-release tablets apprvoed for secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease.

Secondary hyperparathyroidism can lead to significant clinical consequences.

Within 48 hours of taking the drug, many patients saw decreased potassium levels.

Lithium remains a treatment of choice for bipolar disorder, as it is very effective in stabilizing mood and reducing suicide risk. However, its use is associated with adverse renal and thyroid effects.

Study finds chronic hepatitis C has a limited impact on mortality unless the patient has other severe comorbidities.

Although most pharmacies carry a line of natural products, patients often turn to the Internet to find information on those supplements and purchase them.

Amgen's investigational treatment for secondary hyperparathyroidism in patients with chronic kidney disease who are receiving hemodialysis achieved its primary and secondary endpoints in a second Phase 3 study.

New atrial fibrillation treatment guidelines from the American Heart Association and American College of Cardiology clarify the role of novel oral anticoagulants and rate/rhythm control medications.

Our round-up of new generic products.

OTC case studies involving oral ulcerations, fungal infections, immunizations for a patient receiving corticosteroid therapy, and dry mouth.

Compared with previous hypertension treatment guidelines, the JNC 8 guidelines advise higher blood pressure goals and less use of several types of antihypertensive medications.

The medications may lower cholesterol levels in advanced chronic kidney disease patients, but they do not appear to reduce the number of cardiovascular events and may interact with other drugs the patients are taking.

Growth hormone deficiency in children and adults is a disease state that utilizes growth hormone therapy. Here is what specialty pharmacists can do for these patients and what they should know about these conditions.

Diagnosis and treatment of acute coronary syndrome in patients who also have diabetes or chronic kidney disease are challenging for a number of reasons, explains a recently published review article.

Gains in blood pressure control are primarily due to increased use of multiple antihypertensive agents, but hypertension still takes a great toll in terms of health quality and health care costs.

Pharmacists can help slow the progression toward dialysis in patients living with chronic kidney disease.